XML 51 R39.htm IDEA: XBRL DOCUMENT v3.24.1
Stock-Based Compensation (Tables)
6 Months Ended
Jan. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of stock-based awards outstanding by award type
As of January 31, 2024, the following stock-based awards, by award type, were outstanding:
 January 31, 2024
Stock options224,580 
Performance shares827,802 
RSUs, restricted stock, share units and other stock-based awards1,198,832 
Total2,251,214 
Stock-based compensation for awards detailing where recorded in Consolidated Statement of Operations
Stock-based compensation for awards issued is reflected in the following line items in our Condensed Consolidated Statements of Operations:
 Three months ended January 31,Six months ended January 31,
 2024202320242023
Cost of sales$131,000 153,000 $413,000 311,000 
Selling, general and administrative expenses1,991,000 1,015,000 4,167,000 1,663,000 
Research and development expenses67,000 100,000 254,000 198,000 
Stock-based compensation expense before CEO transition costs2,189,000 1,268,000 4,834,000 2,172,000 
CEO transition costs related to equity-classified stock-based awards— — — 3,764,000 
Total stock-based compensation expense before income tax benefit2,189,000 1,268,000 4,834,000 5,936,000 
Estimated income tax benefit(484,000)(293,000)(1,068,000)(786,000)
Net stock-based compensation expense$1,705,000 975,000 $3,766,000 5,150,000 
Summary of stock-based compensation expense by award type
Stock-based compensation expense, by award type, is summarized as follows:
Three months ended January 31,Six months ended January 31,
2024202320242023
Stock options$12,000 19,000 $31,000 44,000 
Performance shares585,000 281,000 942,000 355,000 
RSUs, restricted stock and share units1,566,000 937,000 3,810,000 1,711,000 
ESPP26,000 31,000 51,000 62,000 
Stock-based compensation expense before CEO transition costs2,189,000 1,268,000 4,834,000 2,172,000 
CEO transition costs related to equity-classified stock-based awards— — — 3,764,000 
Total stock-based compensation expense before income tax benefit2,189,000 1,268,000 4,834,000 5,936,000 
Estimated income tax benefit(484,000)(293,000)(1,068,000)(786,000)
Net stock-based compensation expense$1,705,000 975,000 $3,766,000 5,150,000 
Summary of the Plan's activity relating to stock options
The following table summarizes the Plan's activity:
 Awards
(in Shares)
Weighted Average
Exercise Price
Weighted Average
Remaining Contractual
Term (Years)
Aggregate
Intrinsic Value
Outstanding at July 31, 2023240,510 23.96   
Expired/canceled(6,250)24.31   
Outstanding at October 31, 2023234,260 $23.95   
Expired/canceled(9,680)24.25   
Outstanding at January 31, 2024224,580 $23.93 3.58$— 
Exercisable at January 31, 2024201,880 $24.61 3.27$— 
Vested and expected to vest at January 31, 2024223,916 $23.95 3.57$— 
Summary of the Plan's activity relating to performance shares, RSUs, restricted stock and share units
The following table summarizes the Plan's activity relating to performance shares, RSUs, restricted stock, share units and other stock-based awards:
  Awards
(in Shares)
Weighted Average
Grant Date
Fair Value
Aggregate
Intrinsic Value
Outstanding at July 31, 2023 1,876,230 $13.21 
Granted 913,908 9.93 
Settled (296,198)16.03 
Canceled/Forfeited (41,814)15.80 
Outstanding at October 31, 2023 2,452,126 11.60 
Settled (383,565)10.64 
Canceled/Forfeited (41,927)12.78 
Outstanding at January 31, 20242,026,634 $11.76 $12,828,592 
  
Vested at January 31, 2024 452,444 $14.98 $2,863,969 
  
Vested and expected to vest at January 31, 2024 1,960,958 $11.79 $12,412,866